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Abstract
This study examines how parents of pediatric patients might differ in their views and attitudes towards genetic technology and
information when compared to adult patients. There is surprisingly little evidence on how parents compare to other parts of
population in their attitudes. Previous empirical studies often relate health-related preferences and attitudes to factors such as age,
education, and income instead of parental status, thus evading comparison of parents to others as health-related decision makers.
Findings related to the parental status can be useful when implementing genetic technology in clinical practice. We conducted a
survey of views on genetic technology and information for groups of adult neurology patients (n = 68) and parents of pediatric
neurology patients (n = 31) to shed some light on this issue. In addition to our own survey instrument, we conducted other surveys
to gain insight on psychosocial factors that might affect these attitudes. The results suggest that parents are more concerned about
their children’s genetic risk factors when compared to the attitudes of adult patients about their own risk. For both groups,
negative emotional state was associated with more concerns towards genetic information. Our study provides insights on how
parental views might affect the acceptance of genetic technology and information.
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Introduction
Genetic testing plays an important role for the diagnosis of
genetic conditions (Stark et al. 2018). In addition to prognostic
information, early diagnosis can have high diagnostic and
clinical utility (Stark et al. 2018). The perceived utility of
genetic testing extends often even beyond clinically action-
able results as people perceive also informational value in test
results (Halverson et al. 2016). Genetic information can influ-
ence e.g. families’ decision-making, such as parental repro-
ductive planning (Malek et al. 2017; Stark et al. 2019). The
benefits that the new personalized medicine paradigm prom-
ises to accrue are seen mainly come through the increased
utilization of detailed health-related information, not only in
treatment but also possibly in fostering health behavior change
(see, e.g., McBride et al. 2010).
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Last 20 years have thus witnessed a plethora of research on
attitudes towards genetic information (see, e.g., Aro et al.
1997; Jallinoja et al. 1998; Jallinoja and Aro 2000; Morren
et al. 2007; Singer et al. 2008; Vermeulen et al. 2013;
Henneman et al. 2013; Oliveri et al. 2016; LePoire et al.
2018; Vornanen et al. 2018). Generally, attitudes in public
opinion surveys have been found to be rather positive towards
the utilization of genetic information in personalized medicine
(e.g., LePoire et al. 2018). While general public opinion sur-
veys often relate attitudes to individual characteristics such as
gender, age and educational status, parental status has received
rather scant attention. Parental aspect is anyhow one of the key
components when considering the success of genetic counsel-
ing in pediatrics (Fernandez et al. 2014; Sapp et al. 2014).
In recent years, multiple studies have examined views on
genetic information, technology, and the counseling process
also from the viewpoint of parents (see, e.g., Tercyak et al.
2011; Madeo et al. 2014; Goldenberg et al. 2014; Fitzgerald-
Butt et al. 2014; Krabbenborg et al. 2016a; Malek et al. 2017;
Oberg et al. 2018). Overall, the studies point out that parents
have interest and positive attitudes towards genetic technolo-
gy and information (e.g., LePoire et al. 2018). Although rela-
tively good number of studies now document the parental
views on genetics, to our knowledge, much less is known on
how parents fare against other groups when they consider their
sentiments towards genetic medicine. On the other hand, stud-
ies concentrating on parental populations typically evade
comparisons as they examine parents in isolation. Parents
however may have differing needs in terms of information
and counseling process as suggested by Krabbenborg et al.
(2016a). In a parallel study, Krabbenborg et al. (2016b) fo-
cused on psychosocial reactions of parents when obtaining
results of different degree of certainty and found that more
conclusive results seemed to improve parents’ capabilities to
adjust to the situation. Malek et al. (2017) again found that
parents among pediatric cancer patients perceive that genomic
information has psychological and pragmatic utility, even in
the absence of clinical utility. In more general terms beyond
genetic testing, for example, Madeo et al. (2012) have studied
the factors that are associated with greater perceived uncer-
tainty among parents of children with undiagnosed medical
conditions. According to their results, parents experiencing
less control over the illness of their child perceive higher un-
certainty. Given all this, there are reasons to believe that there
is a gap in the literature which would explicitly consider pa-
rental attitudes in contrast to attitudes of other groups, such as
adult patients.
Besides the apparent empirical examination of comparing
parental views to the views of adult patients, our study can
also be placed into the context of wider literature related on
how people react to (medical) information. First, we can relate
our study to the concept of information avoidance which can
be defined as a situation where an individual chooses not to
obtain the information he or she knows exists (see, e.g.,
Golman et al. 2017). In the genetic testing context, for exam-
ple, Clift et al. (2015) and Taber et al. (2015) have found
results suggesting the prevalence of information avoidance
behavior. In other contexts, information avoidance has been
observed in cases such as overall cancer risk (Emanuel et al.
2015; Vrinten et al. 2018) and breast cancer screening take-up
(Goldzahl 2017). The information acquisition or avoidance
behavior has been formally studied using, for example, the
decision models that incorporate anticipatory emotions (see,
e.g., Caplin and Leahy 2001). In these models, uncertain
health outcomes may cause anxiety for the decision maker
and by either obtaining or avoiding information, the decision
maker can try to avoid anxiety. For example, Barbour et al.
(2012) have documented that maintaining hope or denial of
bad health states can both act as motivators to avoid health
information. Information avoidance is also related to psycho-
social factors such as stress. Vrinten et al. (2018) found that
persons with higher levels of psychosocial stress avoid cancer
information more likely. While previous studies have more
often examined how genetic testing influences psychosocial
or psychological wellbeing (e.g., Cameron and Muller 2009;
Oliveri et al. 2018), less is known about how psychosocial
factors are associated with the views of genetic information.
A study by Waisbren et al. (2016) is one of the few previous
studies, which suggested that parental stress is associated with
greater interest in genomic sequencing of newborns.
Second, it is commonly understood that health decisions
involve a significant intertemporal aspect as often the costs
and benefits of health choices accrue at different times (see,
e.g., Attema 2012). This can be especially so in the case of
parents as their decisions concerning their children are gener-
ally long-term decisions. Lastly, it is well established that there
is significant heterogeneity in risk preferences due to individ-
ual characteristics. For example, Görlitz and Tamm (2015)
have suggested that parenthood induces more risk aversive
behavior. Chaulk et al. (2003) have argued that social expec-
tations about the parental behavior might alter the way parents
respond to risk. While we do not explicitly study any of these
mechanisms directly, our study sheds some light about the
possibility of these mechanisms in action in the context of
genetic medicine.
In this study, our interest is to reveal some possible differ-
ences between the parents of child patients and adult patients
in their views towards genetic issues. Moreover, we study
whether there are different psychosocial factors at play behind
these views. To achieve this, we survey their views towards
genetic information and technology with our own question-
naire. In addition, we administer other validated question-
naires to examine the possible psychosocial factors behind
their perceived views (see, e.g., Cameron and Muller 2009).
For adults, we administer RAND-36 (abbreviated RAND
hereafter) and Beck’s Depression Inventory (abbreviated
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BDI hereafter) questionnaires. RAND is a widely applied 36-
item questionnaire on mental and physical well-being of the
respondent. BDI on the other hand is a common tool for
screening symptoms of depression. For parents of child pa-
tients, we administer a questionnaire more suitable to describe
their parental situation, namely Parenting Stress Index (abbre-
viated PSI hereafter) by PAR Inc. (see Abidin 1995), which
measures stressful aspects of parenthood, including subscales
of e.g. depression symptoms and feelings of isolation.
Methods
Study design
The survey data and the corresponding information consent
forms were gathered as a part of a project which aims to
examine the cost-effectiveness of whole-exome sequencing
and its effects on the care trajectories of patients. Our study
design incorporates two groups, parents of child patients and
adult patients, which are compared to each other. As our aim is
not to do a longitudinal analysis of attitudes, cross-sectional
data should be sufficient to describe the possible differences
between the groups and associations between psychosocial
factors and views on genetic issues.
Participants and procedures
The participants were recruited at the pediatric neurology clin-
ic and the adult neurology clinic of Helsinki University
Hospital. Both patient groups were selected for the study by
specialist physicians. Patients presented with neurological dis-
eases of unknown etiology and suspicion of genetic cause,
thus qualifying for the sequencing study. Children in the study
manifested with infantile-onset severe neurological diseases
or childhood-onset progressive neurological disorders and
adult patients presented with severe neuromuscular disorders,
ataxia, hereditary spastic paraparesis, or early Parkinson’s dis-
ease. The recruitment was mainly conducted during years
2016–2017 with continuous recruitment of incoming patients.
Hence, the sampling procedure is a type of convenience sam-
pling in which new participants were recruited as physicians
came across suitable participants within their clinics. Surveys
were distributed in paper form only to those who agreed to
participate (adults: n = 100; parents: n = 47) of which 68 adult
patients and 31 parents of 29 child patients completed the
surveys. All surveys were conducted before any of the patients
had their genetic sequencing done. All index patients who got
molecular genetic diagnosis or their caregivers were discussed
on the heredity of the disease by neurology specialist, and all
those patients or families were offered genetic counseling by a
clinical genetics specialist. Of 19 pediatric patients with ge-
netic diagnosis, 12 families got genetic counseling, 6 are still
waiting for it, and one thought it was unnecessary. Of 20 adult
patients with genetic diagnosis, 16 got genetic counseling by a
clinical geneticist, two elderly patients with no affected rela-
tives got genetic counseling by their treating neurologist, one
is still waiting for it, and one patient could not be contacted
after genetic diagnosis was found. Lastly, this study follows
the ethical standards set out by the coordinating ethical com-
mittee of The Hospital District of Helsinki and Uusimaa.
Measures
There are five survey instruments administered in this study.
The main instrument is our own questionnaire which includes
questions related to attitudes towards genetic information and
technology. For ease of subsequent discussion, we use the
shorthand name “MAIN” to refer to our own survey. Two
versions of the main survey were distributed, one for adult
patients (referred as MAIN-A) and one for parents of child
patients (referred as MAIN-C) (see questions in Table 1). The
MAIN-C version had different wording so that the questions
were formulated from the point of view of a parent, whereas
theMAIN-A survey asked questions from the point of view of
adult patients themselves. Furthermore, for ethical reasons, it
was considered that two of the questions (concerning treatable
and non-treatable secondary findings) included in the adult
patient survey MAIN-A (consisting of 15 questions in total)
would cause unnecessary stress for the parents and hence they
were excluded from MAIN-C survey (consisting of 13 ques-
tions in total). Because of these excluded questions, the num-
bering of the questions is slightly different in child patient
surveys. Thus, we denote different questions by their number
and the letter “A” or “C” to refer either to adult or child survey.
Except for the small change in wording, the remaining set of
questions asks the same issues from both groups.
In theMAIN-surveys we do not construct any overall com-
posite score from the responses, but we analyze mean scores
from each question separately. The translations of survey
forms from Finnish to English along with the scoring of each
question are given in Online Resources 1 & 2. Note that in the
scoring of MAIN surveys, besides actual missing values, the
so called “Cannot say” options (opt-out option) will be
neglected from the calculation of question specific scores.
Besides our own survey instrument, we also administered
three additional questionnaires to gather information about the
psychosocial and physical aspects of respondents’ well-being
and to examine whether there are any specific factors that
correlate with attitudes in our MAIN-surveys. For adult pa-
tients, we administered RAND and BDI questionnaires.When
using RANDwe focus on various subscales, such as “physical
functioning,” “emotional well-being,” and “general health,”
that can be calculated based on the responses. In these
RAND subscales, higher values correspond to more favorable
states. In BDI, however, higher values reflect a more
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depressive state of the respondent. A brief account of these
scoring procedures of RAND and BDI are given in the
Online Resource 3.
For the parents of child patients, we administered the PSI
questionnaire. As earlier mentioned RAND and BDI measure
individuals’ own health and well-being, PSI measures stress-
ful aspects related to parenthood. Since PSI is a commercial
product, we cannot describe the exact procedures of its scoring
or the content of the survey form. What we can however state
here is that similar to RAND, various subscales can be formed
from the PSI responses. These subscales represent for exam-
ple depression symptoms, demandingness of the child, and
feelings of isolation. In addition, PSI allows the formation of
a composite score which represents the overall burden of par-
enthood (total parental domain score). In PSI, higher scores
Table 1 Questions of the MAIN-A and MAIN-C surveys
Q1A/C: My attitude towards the future is positive (trusting) although
there would be significant uncertainty associated with the things im-
portant for me going well.
(1) My attitude is very trusting (2) My attitude is somewhat trusting (3)
My attitude is neither positive or negative (4) My attitude is somewhat
negative (5) My attitude is very negative
Q2A/C: I believe that genetic information improves my quality of life
regardless of the nature of information.
(1) Yes (2) No (.) Cannot say
Q3A/C: I believe that genetic information improves the quality of life of
my close ones regardless of the nature of information.
(1) Yes (2) No (.) Cannot say
Q4A/C: Obtaining test results on inheritable risk factors related to my
own (Q4C: my child’s) health would be important regardless of the
content of the test results.
(1) Yes (2) No (.) Cannot say
Q5A/C: Knowledge that according to the test I have (Q5C: my child has)
genetic risk factors would cause me concern.
(3) Would cause very much concern (2) Would cause some concern (1)
Would not cause any concern (.) Cannot say
Q6A/C: Knowledge that according to the test I have (Q6C: my child has)
genetic risk factors would influence my decisions related to my work
and other issues concerning my personal finances.
(3)Would have large influence (2)Would have some influence (1)Would
not have any influence (.) Cannot say
Q7A: Would you like to hear about such secondary findings concerning
your health, which increase the probability of some other heritable
illness? Let us assume in this case that this illness IS treatable if such
illness later occurs.
(1) I would like to know about this secondary finding (3) I would not like
to know about this secondary finding (2) Secondary finding would
make no difference for me
Q7C: Do you think it would be reasonable that people could obtain
information about disease risk factors related to inheritable conditions
as a part of the general healthcare?
(1) Yes, everybody should be able to obtain information if they wish so
(2) Yes, but information should be given only to those who physician
thinks the information would be useful (3) No, this information should
not be given as a part of general healthcare (.) Cannot say
Q8A: Would you like to hear about such secondary findings concerning
your health, which increase the probability of some other heritable
illness? Let us assume in this case that this illness IS NOT treatable if
such illness later occurs.
(1) I would like to know about this secondary finding (3) I would not like
to know about this secondary finding (2) Secondary finding would
make no difference for me
Q8C: Do you think that information on genotype can be used for medical
research if identity is concealed?
(1) Yes (2) No (.) Cannot say
Q9A: Do you think it would be reasonable that people could obtain
information about disease risk factors related to inheritable conditions
as a part of the general healthcare?
(1) Yes, everybody should be able to obtain information if they wish so
(2) Yes, but information should be given only to those who physician
thinks the information would be useful (3) No, this information should
not be given as a part of general healthcare (.) Cannot say
Q9C: Do you think that information on genotype can be used for other
purpose than medical research (e.g. research on kinship and historical
and societal research) if identity is concealed?
(1) Yes (2) No (.) Cannot say
Table 1 (continued)
Q10A: Do you think that information on genotype can be used for
medical research if identity is concealed?
(1) Yes (2) No (.) Cannot say
Q10C: Given my own financial situation, I would be willing to make a
significant monetary investment on genetic testing to find out the nature
of my/my children’s disease.
(1) Yes (2) No (.) Cannot say
Q11A: Do you think that information on genotype can be used for other
purpose than medical research (e.g. research on kinship and historical and
societal research) if identity is concealed?
(1) Yes (2) No (.) Cannot say
Q11C: If I had the following two options, I would like that:
(1) Test results are provided fast (some weeks) but the results are less
comprehensive (2) Test results are comprehensive but obtaining them
takes more time
Q12A: Given my own financial situation, I would be willing to make a
significant monetary investment on genetic testing to find out the nature
of my/my children’s disease.
(1) Yes (2) No (.) Cannot say
Q12C: If I had the following three options, I would like that:
(1) I tell about the results to my close relatives myself (2) I tell about the
results to my close relatives with the help of my doctor (3) The results
would not be told to close relatives
Q13A: If I had the following two options, I would like that:
(1) Test results are provided fast (some weeks) but the results are less
comprehensive (2) Test results are comprehensive but obtaining them
takes more time
Q13C: Should my close relatives be offered a chance to check their own
genotype for risk factors if my own test results indicate the possibility of
heritable disease?
(1) Should be directly offered the chance (2) Should be offered the chance
from their separate request
(3) Should not be offered this chance at all
Q14A: If I had the following three options, I would like that:
(1) I tell about the results to my close relatives myself (2) I tell about the
results to my close relatives with the help of my doctor (3) The results
would not be told to close relatives
Q15A: Should my close relatives be offered a chance to check their own
genotype for risk factors if my own test results indicate the possibility of
heritable disease?
(1) Should be directly offered the chance (2) Should be offered the chance
from their separate request
(3) Should not be offered this chance at all
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refer to a more negative situation in terms of that subscale.
That is, for example in the case of depression subscale, higher
values correspond to a more depressive/dissatisfied state of
that parent. In the interpretation of these subscales we follow
the 3rd edition of PSI manual (see Abidin 1995).
Data analysis
We analyze the possible differences between genders and be-
tween the groups of parents of child patients and adult patients
in their responses in theMAIN surveys by a standard unpaired
mean comparison t test with the assumption of unequal vari-
ances in the groups. Thus, we compare the average answer
scores between these two groups in each of the questions. We
also test age-related effects on the differences in views be-
tween groups by ANOVA. Since we interpret all the measures
to be ordinal at most, we examine these relationships with a
correlation measure suitable for ordinal data, namely
Kendall’s tau-b correlation coefficient. In addition, we report
Cramer’s V and the p value from the Pearson χ2 test of inde-
pendence between the measures when we examine the rela-
tionship of respondent’s general attitude towards uncertainty
in the future (Q1A/Q1C) of either MAIN-survey with other
questions in the corresponding MAIN surveys. The statistical
significance was set at p value < 0.05. All analyses were done
using the Stata software.
Results
Study sample composition
The composition of the study sample is given in Table 2. In
total, 68 adult patients completed the MAIN-A survey and 31
parents of 29 child patients completed the MAIN-C survey.
Adult patients are on average older than the parents of child
patients (p < 0.001). The slight majority of adult patients are
females. Female patients are also somewhat older on average.
Among parents, mothers are overrepresented as only 3 out of
31 parent respondents are males. There are also twice as many
sons than daughters among child patients. The mean age of
child patients was 6.95 years (SD 5.7).
Differences between adult patients and parents
of child patients on the views of genetic information
Table 3 shows the mean answer scores in adult patient and
parent groups for comparable questions, along with number of
respondents in each question. The frequency tables of answers
for each question in the MAIN-A and MAIN-C surveys are
g iven in Onl ine Resources 4 & 5. In addi t ion ,
Online Resource 6 reports the share of answers by different
groups for each question.
We observe that adult patients have slightly more negative
attitude towards uncertainty in the future than parents (Q1A
vs. Q1C). When comparing the share of answers, less parents
(0%) than adult patients (4.4%) consider their future to be
somewhat negative. Parents express more concern about the
possible genetic risk factors of their child than adult patients
do of their own risk factors (Q5C vs. Q5A. About 22.6% of
parents compared to 5.9% adults think that knowledge of pos-
sible genetic risk factors would cause concern very much. We
also observe that adult patients were somewhat more willing
to wait for more comprehensive results whereas parents
expressed slight tendency to be more impatient to obtain the
results (Q13A vs. Q11C). About 25.8% of parents compared
to 7.4% of adults think that test results would be better pro-
vided fast and less comprehensive than more comprehensive
but obtaining test results takes more time.
While adult patients were on average older than the parents
of child patients, we tested if some of the differences on the
views between the groups are driven by possible age-related
effects. However, our analysis did not show age-related ef-
fects, while interaction terms between age and group variables
were not statistically significant (data not shown).
Table 2 Sample characteristics
N (%) Mean age SD Median Min Max
Adult patients 68 (100) 49.60 14.76 49.5 18 81
Male 30 (44.12) 46.97 12.73 47 19 69
Female 38 (55.88) 51.68 16.05 55 18 81
Child gender
Male Female Missing
Parents of child patients 31 (100) 37.29 7.17 37 26 57
Male 3 (9.68) 37.33 5.69 39 31 42 2 1 0
Female 28 (90.32) 37.29 7.40 37 26 57 19 8 1
Child patients 29 (100) 6.95* 5.7 5 0.17 16
*Age measured in full years. For two child patients, the information on age was missing. Gender information on one child was missing
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We also analyzed how the general attitude towards un-
certainty in the future (Q1A/C) was associated with the
other questions in the MAIN survey in both groups
(Table 4). Among adult patients, the association between
the general attitude towards uncertainty (Q1A) and impor-
tance of obtaining the risk factors related to health (Q4A)
was positive and thus indicates that negativity is associat-
ed with smaller importance placed on genetic information.
However, this finding is driven by only very few respon-
dents answering “No” as the vast majority of adult pa-
tients saw genetic information important regardless of
the results. Parents who have more negative general atti-
tude towards uncertainty in the future see that genetic
information would improve the quality of life of their
closest ones (Q3C). However, only about half of the par-
ent sample had some clear opinion on this and the other
half (n = 14) responded the “Cannot say” option, reducing
the sample size in this question significantly. More nega-
tivity towards uncertainty in the future in parents is asso-
ciated with the desire to make significant adjustments to
work life and economic decisions when they learn the
genetic risk factors (Q6C).
Associations between psychosocial factors
and the general attitude towards uncertainty
in the future and views towards genetic information
Since there are only two significant correlations between the
MAIN-A and BDI, we do not tabulate but report them here
within the text. The general attitude towards uncertainty in the
future (Q1A) was significantly correlated with BDI (0.40,
p < 0.001). We see that higher negativity is positively corre-
lated with the degree of depression symptoms. This gives us
some assurance that attitude towards uncertainty in the future
has succeeded to extract reasonably well at least some aspect
of respondent’s world view. In addition, there was a weak but
significant correlation between BDI and concerns to genetic
information (Q5A: 0.23, p = 0.035). Note that BDI score is
highly correlated also with the emotional well-being compo-
nent of RAND36, with a coefficient of − 0.49, p < 0.001.
As we see from Table 5, most significant correlations with
RAND components are negative. For example, when the emo-
tional well-being in RAND scores increases, the score in gen-
eral attitude towards uncertainty decreases, implying more
positive attitude towards the future. Overall, attitude towards
Table 3 Mean answers by adult patients and parents of child patients
Adults Parents
MAIN-A Mean N Cannot
say (N)




Q1A Attitude towards uncertainty 2.045 66 – Q1C Attitude towards uncertainty 1.806 31 – 0.239 0.1047
Q2A Own QoL 1.078 51 16 Q2C Own QoL 1.136 22 9 − 0.058 0.4953
Q3AThe QoL of the close ones 1.102 49 18 Q3C The QoL of the close ones 1.118 17 14 − 0.016 0.8661
Q4A Importance of test results on
inheritable risk factors
1.048 63 4 Q4C Importance of test results on
inheritable risk factors
1.036 28 3 0.012 0.7914
Q5A Concern towards the knowledge of
genetic risk factors
1.803 61 5 Q5C Concern towards the knowledge of
genetic risk factors
2.111 27 3 − 0.308 0.0351
Q6A Influence of genetic risk factors on
work life and financial decisions
1.642 53 14 Q6C Influence of genetic risk factors on
work life and financial decisions
1.692 26 5 − 0.050 0.7247
Q7ATreatable secondary findings 1.000 67 –
Q8A Non-treatable secondary findings 1.269 67 –
Q9A Attitude towards genetic
information as a part of healthcare
1.323 65 2 Q7C Attitude towards genetic
information as a part of healthcare
1.448 29 1 − 0.125 0.3291
Q10AGenetic privacy and medical use of
results
1.000 63 4 Q8C Genetic privacy and medical use of
results
1.000 30 1 0.000 –
Q11A Genetic privacy and other than
medical use of results
1.050 60 7 Q9C Genetic privacy and other than
medical use of results
1.080 25 6 − 0.030 0.6325
Q12A Monetary investments 1.356 45 22 Q10C Monetary investments 1.250 16 14 0.106 0.4342
Q13A Availability of test results 1.925 67 – Q11C Availability of test results 1.742 31 – 0.183 0.0395
Q14A Informing relatives about test
results
1.303 66 – Q12C Informing relatives about test
results
1.267 30 – 0.036 0.7443
Q15A Possibility of heritable disease 1.433 67 – Q13C Possibility of heritable disease 1.516 31 – − 0.083 0.4510
Comparable questions from MAIN-A (adult patient survey) and MAIN-C (parent survey) next to each other. “Mean” refers to the mean score in the
corresponding question. “Difference” refers to the difference between the mean scores. “N” is number of respondents. Note that the sum of respondents
may not be 68 (adults) or 31 (parents) as there can be either “Cannot say” or truly missing values which are not included in the calculations of mean score
QoL quality of life
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uncertainty in the future correlates significantly with many of
the RAND components, indicating that attitude towards un-
certainty (O1A) gives somewhat consistent view of respon-
dent’s sentiment also when compared to RAND.
Physical functioning component is positively correlated
with the influence of genetic risk factors on the decisions
related to work and other issues concerning respondent’s per-
sonal finances (Q6A). Intuitively those who are physically in
better condition can also better adjust their lives in terms of
work life and household economy. On the other hand, the ones
who are emotionally better off (“Emotional well-being”) may
see little need for changes, thus the negative correlation with
the influence of genetic risk factors on work life and financial
decisions (Q6A). Concern towards the knowledge of genetic
risk factors (Q5A) correlates significantly with emotional
components of RAND, implying that lower emotional well-
being is associated with higher concerns due to genetic
information.
In Table 6, we list all the significant correlations between
MAIN-C questions and any of the subscale scores in PSI.
However, in some of the questions, the correlation can be
driven by only few observations (see Online Resource 5).













Q1A Attitude towards uncertainty 1 0.000 1 0.000 Q1C Attitude towards uncertainty 1 0.000 1 0.000
Q2A Own QoL 0.21 0.114 0.28 0.266 Q2C Own QoL 0.05 0.867 0.28 0.436
Q3AThe QoL of the close ones 0.21 0.134 0.27 0.312 Q3C The QoL of the close ones − 0.52 0.041 0.57 0.066
Q4A Importance of test results on
inheritable risk factors
0.29 0.017 0.44 0.008 Q4C Importance of test results on
inheritable risk factors
0.07 0.763 0.13 0.782
Q5A Concern towards the knowledge of
genetic risk factors
0.23 0.060 0.25 0.286 Q5C Concern towards the knowledge of
genetic risk factors
0.25 0.175 0.20 0.692
Q6A Influence of genetic risk factors on
work life and financial decisions
0.10 0.452 0.26 0.303 Q6C Influence of genetic risk factors on
work life and financial decisions
0.52 0.007 0.44 0.039
Q7ATreatable secondary findings NA NA NA NA
Q8A Non-treatable secondary findings 0.21 0.075 0.24 0.279
Q9A Attitude towards genetic
information as a part of healthcare
0.16 0.183 0.20 0.513 Q7C Attitude towards genetic
information as a part of healthcare
− 0.35 0.053 0.31 0.233
Q10A Genetic privacy and medical use
of results
NA NA NA NA Q8C Genetic privacy and medical use of
results
NA NA NA NA
Q11A Genetic privacy and other than
medical use of results
− 0.00 1.000 0.10 0.896 Q9C Genetic privacy and other than
medical use of results
0.07 0.768 0.22 0.543
Q12A Monetary investments 0.15 0.296 0.29 0.292 Q10C Monetary investments 0.17 0.551 0.45 0.195
Q13A Availability of test results − 0.07 0.570 0.15 0.669 Q11C Availability of test results 0.07 0.734 0.14 0.749
Q14A Informing relatives about test
results
− 0.02 0.900 0.21 0.395 Q12C Informing relatives about test
results
− 0.01 0.977 0.24 0.508
Q15A Possibility of heritable disease 0.07 0.536 0.18 0.528 Q13C Possibility of heritable disease 0.11 0.537 0.12 0.792
Comparable questions from MAIN-A (adult patient survey) and MAIN-C (parent survey) next to each other
NA not available (no variation)
Table 5 Significant correlations between RAND components and MAIN-A questions
MAIN-A Question RAND component Correlation coefficient p value
Q1 Attitude towards uncertainty Physical role limitations − 0.26 0.013
Q1 Attitude towards uncertainty Energy/fatigue − 0.33 0.001
Q1 Attitude towards uncertainty Emotional well-being − 0.38 0.000
Q1 Attitude towards uncertainty Social functioning − 0.28 0.006
Q1 Attitude towards uncertainty General health − 0.33 0.001
Q5 Concern towards the knowledge of genetic risk factors Emotional role limitations − 0.33 0.006
Q5 Concern towards the knowledge of genetic risk factors Emotional well-being − 0.23 0.031
Q6 Influence of genetic risk factors on work life and financial decisions Physical functioning 0.34 0.004
Q6 Influence of genetic risk factors on work life and financial decisions Emotional well-being − 0.36 0.002
RAND components are subscores of RAND-36 survey measure and MAIN-A refers to our own survey for adult patients
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We see that for parents with more depression symptoms and
feelings of isolation, the knowledge of the genetic risk factors
of their child is associated with higher impact of this informa-
tion on their work life and economic decisions (Q6C). Q6C is
also correlated with the total parental domain score, implying
that overall challenges in parenting seem to be associated with
higher influence of genetic information on work life and fi-
nancial decisions.
We interestingly found a negative relationship between
willingness to invest financially on genetic examinations
(Q10C) and how parents feel that their child has been demand-
ing in terms of care, but many (n = 14) answered “Cannot
say.” Parents who have felt elevated stress about the demands
of the child are in fact more likely to invest. The occurrence of
depression symptoms is associated with a desire to limit the
availability of testing to close relatives (Q13C).
Gender differences among adult patients
As suggested, gender differences may drive the responses.
Thus, we examine whether there are significant differences
in responses between genders among adult patients. In
Table 7, we see that mean answer scores in the MAIN-A
survey do not statistically significantly differ between male
and female respondents. Thus, it seems that at least in statis-
tical sense neither of the genders seems to drive the overall
adult patient responses too much. As a consequence, we con-
sider that we can use the adult sample as a whole when we
compare them to the group of parents, which is mostly
females.
Females show slightly more concern due to findings of
genetic risk factors (Q5A) than males as higher values are
related to more expressed concern. We see that genetic infor-
mation would have slightly more influence on work life and
financial decisions (Q6A) for males than females. Female re-
spondents are somewhat more cautious in terms of obtaining
information on genetic risk factors directly as a part of
healthcare (Q9A). Women had somewhat more reservations
in terms of informing relatives about the results or at least they
prefer to have more help from physicians (Q14A). Note that in
the outset of the questionwe explicitly defined also children as
close relatives. However, all adult respondents were
unanimous in their responses with the questions about treat-
able secondary findings (Q7A) and both groups about genetic
privacy and medical use of results (Q10A and Q8C).
Discussion
This study is one of the few studies that compare the views of
parents of child patients on genetic information to some other
group, in this study to the adult patients. Previous studies have
found that in general parents have positive attitudes towards
genetic information (e.g., Fitzgerald-Butt et al. 2014; Dodson
et al. 2015; LePoire et al. 2018). In summary, our results
suggest some statistically significant differences between par-
ents and adult patients in their views towards genetic informa-
tion and technology. Adult patients showed more negative
attitudes towards uncertainty in future life, as parents, who
on average were younger, may account also for their own
(better) physical functionality when judging their future. On
the other hand, parents seem to express more concern when
they learn about the genetic risk factors of their child than
what adult patients do when learning about their own risk.
However, also many of the adult patients have probably chil-
dren and can have fear of possible hereditary. Our results are
still in line with the study by Aktan-Collan et al. (2011) who
found that parents felt that discussing about children’s risk of
hereditary cancer is the most difficult communication aspect
compared to, e.g., discussing to parents’ own risk. Our results
also indicate that while both groups on a whole prefer more
comprehensive testing results over faster but less comprehen-
sive ones, more parents would anyhow rather have results
available faster. In both groups, negative emotional state was
associated with more concerns towards genetic information.
Neither group seemed to show major signs of information
avoidance tendencies as both groups overall saw that genetic
information will improve the quality of their own and their
close relatives’ lives. However, almost a half of parents of
child patients could not respond to this question, which is
understandable as genomic information is unknown before
sequencing. The relatively large degree of similarity of views
towards genetic issues observed in our study can be explained
by the same initial situation as both groups were faced with a
Table 6 Significant correlations between MAIN-C questions and PSI subscales
MAIN-C PSI subscale Correlation coefficient p value
Q6 Influence of genetic risk factors on work life and financial decisions Isolation 0.42 0.103
Q6 Influence of genetic risk factors on work life and financial decisions Depression 0.39 0.018
Q6 Influence of genetic risk factors on work life and financial decisions Total parental domain score 0.37 0.023
Q10 Monetary investments Demanding − 0.45 0.045
Q13 Possibility of heritable disease Depression 0.31 0.047
PSI subscales are subscores of PSI survey measure and MAIN-C refers to our own survey for the parents of child patients.
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new genetic sequencing technology personally. Our study in-
dicates that mostly emotional factors, such as depressive state
of mind, seemed to be associated with higher concern about
the genetic information in both groups. However, due to the
small samples we must use caution in making too strong con-
clusions as some correlations related to psychosocial factors
might be driven by very few observations. In other contexts,
the higher levels of psychosocial stress have been found to be
associated with cancer-related fear and information avoidance
(Vrinten et al. 2018).
Related to the intertemporal aspect of decision making,
parents seemed more forward looking than adult patients, thus
suggesting different time preferences and planning horizons.
On the other hand, impatience of parents to receive results
would suggest their desire to resolve uncertainty faster. That
is, parents seem to express some preference towards faster
resolution of uncertainty regardless of resolution being some-
what incomplete. One possible explanation is that parents pre-
fer earlier resolution in order to adjust health investment, work
life, and financial decisions more effectively. Indeed, based on
our results it seemed that parents were quite keen to obtain
genetic information. Such observations would suggest that
parents want to avoid the discomfort caused by uncertainty
due to lack of information. This is in line with the study by
Görlitz and Tamm (2015), who suggested that parenthood
induces more risk aversive behavior. In addition, Malek
et al. (2017) reported that parents perceive genomic informa-
tion in pediatric cancer context to have significant benefits for
themselves but also their other family members. Naturally
many other factors could affect here as age and current health
status (of the patient) related effects could also explain the
differences in the observed time and coverage preferences.
For example, Ferecatu and Önçüler (2016) have suggested
that impatience decreases with age.
Parents’ willingness to make economic and work life ad-
justments was associatedwith more negative attitudes towards
uncertainty in the future and depression symptoms. Similar
association was observed with adult patients. Also having a
more demanding child increased the likelihood that parents
invested on finding genetic risk factors as parents who have
had it easier with the child may not feel as pressed to find out
possible genetic factors behind child’s behavior. This in line
with the finding of a previous study that those parents whose
child has two or more health conditions are more likely to be
interested in genomic information (Dodson et al. 2015). Also,
a study by Waisbren et al. (2016) found that parental stress
was associated with greater interest in genomic sequencing.
However, in our study, it is difficult to draw any exact conclu-
sions from parents’ willingness to make economic and work
life adjustments as we have no information on what type of
financial constraints the groups on average have. Both groups
were observed to be unanimous about the medical use of the
results.
When comparing the results between adult patients and the
parents of child patients we need to keep in mind the gender
distributions as gender differences may drive the responses.
Our study showed that female respondents among adult
patients were somewhat more cautious in terms of obtaining
Table 7 Mean answers in MAIN-A questions by genders
All Males Females
Question Mean N Mean N Mean N Difference p value
Q1 Attitude towards uncertainty 2.045 66 2.103 29 2.000 37 0.10 0.605
Q2 Own QoL 1.078 51 1.143 21 1.033 30 0.11 0.209
Q3 The QoL of the close ones 1.102 49 1.056 18 1.129 31 − 0.07 0.379
Q4 Importance of test results on inheritable risk factors 1.048 63 1.037 27 1.056 36 − 0.02 0.731
Q5 Concern towards the knowledge of genetic risk factors 1.803 61 1.704 27 1.882 34 − 0.18 0.192
Q6 Influence of genetic risk factors on work life and financial decisions 1.642 53 1.720 25 1.571 28 0.15 0.330
Q7 Treatable secondary findings 1.000 67 1.0 29 1.000 38 0.00 –
Q8 Non-treatable secondary findings 1.269 67 1.2 29 1.289 38 − 0.05 0.769
Q9 Attitude towards genetic information as a part of healthcare 1.323 65 1.2 28 1.405 37 − 0.19 0.166
Q10 Genetic privacy and medical use of results 1.000 63 1.0 27 1.000 36 0.00 –
Q11 Genetic privacy and other than medical use of results 1.050 60 1.037 27 1.061 33 − 0.02 0.676
Q12 Monetary investments 1.356 45 1.318 22 1.391 23 − 0.07 0.618
Q13 Availability of test results 1.925 67 1.966 29 1.895 38 0.07 0.251
Q14 Informing relatives about test results 1.303 66 1.241 29 1.351 37 − 0.11 0.336
Q15 Possibility of heritable disease 1.433 67 1.483 29 1.395 38 0.09 0.481
“Mean” refers to the mean score in the corresponding question. “Difference” refers to the difference between the mean scores. “N” is number of
respondents. Note that the sum of respondents may not be 68 as there can be either “Cannot say” or truly missing values which are not included in the
calculations of mean score
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genetic risk factors directly as a part of healthcare. Aro et al.
(1997) and more recently Vermeulen et al. (2013) have found
gender differences in attitudes towards genetic issues. The
study by Aro et al. (1997) suggested that men are more favor-
able towards genetic testing. However, the views differ ac-
cording to age and education. Vermeulen et al. (2013) found
that females are more favorable to assessing family history.
Our study also showed that women had somewhat more res-
ervations in terms of disclosing the results to relatives. In
general, it is often observed that support and guidance is need-
ed in terms of information disclosing, especially when consid-
ering whether or not one should let their children know about
the results (see, e.g., Tercyak et al. 2007; Cameron and Muller
2009; Madeo et al. 2014). Lastly, although it is possible that
the gender of a child is associated with certain type of parental
behavior and family development (see, e.g., Lundberg 2005),
usually such association is considered for paternal behavior
while our group of parents mostly consisted mothers.
The limitations of study
As always, our study is not devoid of limitations. Empirical
studies which attempt to elicit preferences, attitudes, and be-
havior or model relationship between these in the health con-
text often have some situational limitations which undermine
the generalizability of the results. One common limitation is
that attitudes or preferences are elicited using hypothetical
scenarios which may not reflect well the actual decision-
making situation (see, e.g., Goldenberg et al. 2014). This
may be the case also with some of our survey questions.
Because of some pre-conditions for participation, small and
highly selected samples pose a challenge in many studies.
This limitation certainly concerns our study and thus the re-
sults should be interpreted accordingly. Small sample size and
“Cannot say” answers can decrease statistical power to find
some differences between the groups. A post hoc power anal-
ysis is not a univocally accepted method to validate research
findings (see, e.g., Hoenig and Heisey 2001), so we acknowl-
edge that a priori power analysis to determine a sufficient
sample size for example might have been valuable, but on
the other hand, convenience sampling in our study poses some
challenges to this also as a priori a high degree of uncertainty
is related to the achieved sample size in this approach. Given
that the participants were selected by professionals within
their own clinics obviously limits the generalizability of our
sample. In addition, the sample only considers individuals
with sufficient skills in Finnish language since the surveys
were administered in Finnish.
Additional criticism towards our data set is that we con-
ducted a survey of attitudes for a sample of individuals who
are about to have firsthand experience on genetic sequencing
technology, either as a parent or patient. Thus, respondents are
probably inclined to have more positive views to begin with.
In addition, the recruited child and adult patients in this study
had different diseases being partly more severe among child
neurology patients (e.g., encephalopathy), which might affect
the attitudes of parents of child patients. However, comparison
within a medical specialty (neurology) in a clinical setting
might provide more relevant information from the perspective
of clinical practice compared to large-scale general public
opinion surveys in which parts of the study population may
have rather limited interest towards the topic. It is also note-
worthy that studies tend to be context specific and insights
from one domain such as financial domain may be hard to
transmit to health domain (see, e.g., Galizzi 2014). Even if
we stay within the health domain, we might observe varia-
tions, for example, in risk attitudes (van der Pol and Ruggeri
2008; Ruggeri and van der Pol 2012). For example, Cameron
et al. (2009) show that the way how people view genetic
testing and their results depends on the perceived riskiness
of the disease under testing. Thus, making wide ranging pol-
icy recommendations based on a few disease/condition spe-
cific empirical studies would not be advisable.
We also cannot infer the overall level of understanding that
the respondents possess on the issues of inheritance and ge-
netics (see, e.g., Henderson and Maguire 2000). Significant
differences in this understanding can shape attitudes accord-
ingly. For example, knowledge of genetic testing can differ
due to varying understanding of the role of genes in diseases
(Henderson and Maguire 2000; Haga et al. 2013). Some indi-
viduals believe that genetic diseases are something that you
cannot avoid if it is inherited, but some understand that you
can also be carrier, not necessarily sufferer (Henderson and
Maguire 2000). As said, in our setting, all respondents can be
assumed to be relatively well informed about the nature of the
sequencing that the patients are about to experience.
As our survey was built to indicate views on wide variety of
issues related to the genetic topics, typical considerations of
validity and reliability focusing on the ability of the instrument
to measure some single underlying construct were not applied
in this context. Thus, it was considered that slightly differing
surveys for the two groups would not pose a challenge for our
analysis. Anyhow, since the condition of their child is quite
sensitive issue for the parents, we saw that administering a
slightly modified survey would better elicit their views than
distributing the exact same form than what adult patients re-
ceived. Furthermore, given that the survey was built only for
the specific purpose of this study, we considered that an internal
evaluation of the appropriateness of the survey form among
research group members was sufficient. We however acknowl-
edge that in possible future analyses of the issue, the survey
should be developed further. We cannot for example rule out
that the wording of the questions might have some effect on the
answers. Lastly, while we know howmany of those who agreed
to participate to the study ultimately filled the forms, we have
no information on how many declined to participate.
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Implications for practice
According to our results, the counseling process related to new
genetic technologies should account for the different views that
parents of child patients and adult patients have towards genetic
information. Thus, the counseling process might need to be
adapted to cover wider support needs than just the immediate
clinical support. The situations of parents may differ with re-
spect to how demanding the child is, thus suggesting that the
counseling might need to be adjusted accordingly.
Possible avenues for future research
Many aspects of methodology and data in our study could be
improved upon. For example, our comparison could include a
non-treatment group who is not going to experience genetic
sequencing at all. Our study also suggests some interesting
themes for future research. There is some indication that the
social isolation and feelings of parental failure/incompetence
are possibly fruitful avenues to study further in this context.
For example, Krabbenborg et al. (2016b) identified some par-
ents felt certain type of isolation after receiving genetic testing
results as the results acted as a sort of label on their child.
Another topic that would warrant a further study relates to the
willingness of parents to invest time, money, and effort to ge-
netic examinations. This would require detailed background
information on the financial situation of different households.
Conclusions
In this paper, we have studied how the attitudes of parents of
child patients towards genetic information may differ from
adult patients. In general, our study provides insights on possi-
ble factors which could have an impact on parental decision
making in the genetic medicine context. Our study hints that
parents may differ as users of genetic information from the
others. We also observed that negative emotional state was
associated with more concerns towards genetic information.
From the perspective of health policy aiming to foster accep-
tance of genetic technology, we suggest that based on our re-
sults, parental aspect of decision making should be recognized.
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